ASX AnnouncementPercheron Therapeutics LimitedABN 41 095 060 745ASX: PER | FSE: AWY | US OTC: ATHJY RESULTS OF ANNUAL GENERAL MEETING Melbourne, Australia – 7 October 2026: Percheron Therapeutics Limited (ASX:PER or “the Company”) is pleased to advise the results of today’s Annual...
Percheron Therapeutics: Results of Annual General Meeting
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The filing includes a summary of the poll voting results by proxies on each resolution considered at the meeting. All resolutions were decided on a poll, and the Board expressed gratitude to shareholders for their participation.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Percheron Therapeutics Limited on 6ix
In the deck
Story so far
Earlier from Percheron Therapeutics
- Annual General Meeting - Management Presentation
- Annual General Meeting - Chair Address
- Proposed issue of securities - PER
- Final Director's Interest Notice
- Initial Director's Interest Notice
Later from Percheron Therapeutics
- Notification regarding unquoted securities - PER
- Change of Director's Interest Notice
- Application for quotation of securities - PER
- Notice under S708A
- PER: Percheron and Invion Explore Cancer Combination Therapy
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics